Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Monday, November 19, 2018 · 468,774,054 Articles · 3+ Million Readers

Global Immunohistochemistry Market is Estimated to Reach a Value of $3.1 Billion by 2025

/EIN News/ -- Dublin, Nov. 09, 2018 (GLOBE NEWSWIRE) -- The "Immunohistochemistry Market Size, Share & Trends Analysis Report By Application (Diagnostics, Drug Testing), By Product (Antibodies, Reagents, Equipment, Kits), By End Use, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global immunohistochemistry market size is estimated to reach a value of USD 3.1 billion by 2025. It is anticipated to witness a revenue-based CAGR of 8.8% over the forecast period. High prevalence of cancer and increasing healthcare expenses driven by expanding aging population base are recognized as the most influential factors driving the market.


Cancer has high morbidity and mortality risk. Diagnosis of this disease majorly depends on the stage of the disease at admission. This has led to high demand of immunohistochemistry (IHC) products.


IHC staining process is performed on cancer tissues to reveal the presence of HER2 receptors and/or hormone receptors on their surface. This information plays a vital role in planning cancer treatment. This factor is anticipated to drive demand in near future.


In addition, rising popularity of targeted immunotherapy and biologic therapy for anticancer drug development and increasing Food and Drug Administration (FDA) approvals are expected to boost market growth in near future.


Significant rise in healthcare spending and shift in focus on value-based healthcare solutions can further impel growth of the immunohistochemistry market over the forecast period.


According to the Centers of Medicare & Medicaid Services (CMS) projections, the National Health Expenditure is anticipated to rise at an average of 5.5% every year from 2017 to 2026. It is expected to reach around USD 5.7 trillion by 2026. Hospitals and care facilities are adopting a more specific and targeted therapy for better outcomes and to establish a move value-based healthcare delivery.


Further key findings from the study suggest:

  • Antibody segment accounted for the largest market share due to rising regulatory approvals for therapeutic antibody products
  • North America registered the highest CAGR in 2017 owing to well-established healthcare infrastructure and favorable reimbursements
  • APAC is expected to witness the fastest CAGR owing to increasing healthcare expenses and aging population
  • Diagnostics segment dominated the immunohistochemistry market in 2017 owing to high prevalence of cancer and other such chronic diseases
  • Hospitals and diagnostic laboratories is anticipated to exhibit significant CAGR over the forecast period due to increasing disease prevalence and high number of these facilities with advanced infrastructure
  • Some of the key market players are Abcam plc; Agilent Technologies; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc

Key Topics Covered

Chapter 1 Executive Summary

Chapter 2 Research Methodology
2.1 Country Wise Market: Base Estimates
2.2 Global Market: CAGR Calculation
2.3 Region Based Segment Share Calculation
2.4 Research Scope & Assumptions
2.5 List of Data Sources
2.5.1 Data for primary interviews, by sources
2.5.2 Data for primary interviews, by region
2.6 Market Snapshot

Chapter 3 Immunohistochemistry Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increase in prevalence of chronic diseases
3.2.2 Growing geriatric population
3.2.3 Rise in healthcare spending
3.3 Market Restraint Analysis
3.3.1 Limitations associated with IHC techniques
3.3.2 High cost of automated IHC instruments
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by product
3.4.2 Key opportunities prioritized, by application
3.4.3 Key opportunities prioritized, by end use
3.5 Immunohistochemistry - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter's
3.7 Immunohistochemistry Market: Market Position Analysis, 2017

Chapter 4 Immunohistochemistry Market: Product Estimates & Trend Analysis
4.1 Immunohistochemistry Market: Product Movement Analysis
4.2 Antibodies
4.2.1 Antibodies market, 2014 - 2025 (USD Million)
4.2.2 Primary antibodies
4.2.2.1 Primary antibodies market, 2014 - 2025 (USD Million)
4.2.3 Secondary antibodies
4.2.3.1 Secondary antibodies market, 2014 - 2025 (USD Million)
4.3 Equipment
4.3.1 Equipment market, 2014 - 2025 (USD Million)
4.3.2 Slide staining systems
4.3.2.1 Slide staining systems market, 2014 - 2025 (USD Million)
4.3.3 Tissue microarrays
4.3.3.1 Tissue microarrays market, 2014 - 2025 (USD Million)
4.3.4 Tissue processing systems
4.3.4.1 Tissue processing systems market, 2014 - 2025 (USD Million)
4.3.5 Slide scanners
4.3.5.1 Slide scanners market, 2014 - 2025 (USD Million)
4.3.6 Other equipment
4.3.6.1 Other equipment market, 2014 - 2025 (USD Million)
4.4 Reagents
4.4.1 Reagents market, 2014 - 2025 (USD Million)
4.4.2 Histological stains
4.4.2.1 Histological stains market, 2014 - 2025 (USD Million)
4.4.3 Blocking sera and reagents
4.4.3.1 Blocking sera and reagents market, 2014 - 2025 (USD Million)
4.4.4 Chromogenic substrates
4.4.4.1 Chromogenic substrates market, 2014 - 2025 (USD Million)
4.4.5 Fixation reagents
4.4.5.1 Fixation reagents market, 2014 - 2025 (USD Million)
4.4.6 Stabilizers
4.4.6.1 Stabilizers market, 2014 - 2025 (USD Million)
4.4.7 Organic solvents
4.4.7.1 Organic solvents market, 2014 - 2025 (USD Million)
4.4.8 Proteolytic enzymes
4.4.8.1 Proteolytic enzymes market, 2014 - 2025 (USD Million)
4.4.9 Diluents
4.4.9.1 Diluents market, 2014 - 2025 (USD Million)
4.5 Kits
4.5.1 Kits market, 2014 - 2025 (USD Million)

Chapter 5 Immunohistochemistry Market: Application Estimates & Trend Analysis
5.1 Immunohistochemistry Market: Application Movement Analysis
5.2 Diagnostics
5.2.1 Diagnostics market, 2014 - 2025 (USD Million)
5.2.2 Cancer
5.2.2.1 Cancer market, 2014 - 2025 (USD Million)
5.2.3 Infectious diseases
5.2.3.1 Infectious diseases market, 2014 - 2025 (USD Million)
5.2.4 Cardiovascular disease
5.2.4.1 Cardiovascular disease market, 2014 - 2025 (USD Million)
5.2.5 Autoimmune diseases
5.2.5.1 Autoimmune diseases market, 2014 - 2025 (USD Million)
5.2.6 Diabetes mellitus
5.2.6.1 Diabetes mellitus market, 2014 - 2025 (USD Million)
5.2.7 Nephrological diseases
5.2.7.1 Nephrological diseases market, 2014 - 2025 (USD Million)
5.3 Drug Testing
5.3.1 Drug testing market, 2014 - 2025 (USD Million)

Chapter 6 Immunohistochemistry Market: End Use Estimates & Trend Analysis
6.1 Immunohistochemistry Market: End Use Movement Analysis
6.2 Hospitals and Diagnostic Laboratories
6.2.1 Hospitals and diagnostic laboratories market, 2014 - 2025 (USD Million)
6.3 Research Institutes
6.3.1 Research institutes market, 2014 - 2025 (USD Million)
6.4 Other End Use
6.4.1 Other end use market, 2014 - 2025 (USD Million)

Chapter 7 Immunohistochemistry Market: Regional Estimates & Trend Analysis, by Product, Application, End Use
7.1 Immunohistochemistry Market Share by Region, 2014 & 2025
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.6 MEA
7.6.1 South Africa

Chapter 8 Competitive Landscape
8.1 Company Profile
8.1.1 Thermo Fisher Scientific, Inc.
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.2 F. Hoffmann-La Roche Ltd.
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.3 Merck KGaA
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Danaher
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 PerkinElmer, Inc.
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Bio-Rad Laboratories, Inc.
8.1.6.1 Company Overview
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.7 Cell Signaling Technology, Inc.
8.1.7.1 Company Overview
8.1.7.2 Product Benchmarking
8.1.7.3 Strategic Initiatives
8.1.8 Bio SB
8.1.8.1 Company Overview
8.1.8.2 Product Benchmarking
8.1.8.3 Strategic Initiatives
8.1.9 Agilent Technologies
8.1.9.1 Company Overview
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.10 Abcam plc
8.1.10.1 Company Overview
8.1.10.2 Financial Performance
8.1.10.3 Product Benchmarking

For more information about this report visit https://www.researchandmarkets.com/research/wj6hjc/global?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: In Vitro Diagnostics
                    

22157.jpg

Powered by EIN News